Article Information
History
- November 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Md Khadem Ali1,2,
- Yu Liu3,4,
- Katharina Schimmel1,2,3,
- Nicholas H. Juul5,
- Courtney A. Stockman5,
- Joseph C. Wu3,4,6 and
- Edda F. Spiekerkoetter1,2,*
- 1Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, USA
- 2Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, USA
- 3Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA
- 4Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 5Institute for Stem Cell Biology and Regenerative Medicine, Division of Pulmonary Allergy and Critical Care Medicine
- 6Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
- ↵*Corresponding author: Edda Spiekerkoetter, MD, Associate Professor of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA, Phone: +1 (650) 739-5031, Email: eddas{at}stanford.edu
Posted November 26, 2022.
Identifying transcriptomic downstream targets of genes commonly mutated in Hereditary Hemorrhagic Telangiectasia
